<DOC>
	<DOCNO>NCT00863785</DOCNO>
	<brief_summary>35 % Acute Alcoholic Hepatitis patient ( AAH ) respond corticoid die 6 month . Chronic alcohol abuse deplete glutathione hepatocytes make latter sensitive excessive TNFα level . Re-establishment stock antioxidant administration precursor ( N-acetyl cysteine , NAC ) combination corticoid ( C ) could make hepatocytes resistant improve survival . The investigator ' study 's primary endpoint improvement survival 6 month . The secondary endpoint survival 1 3 month , tolerance NAC drop blood bilirubin level D7</brief_summary>
	<brief_title>Treatment Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone</brief_title>
	<detailed_description>AAH patient ( Maddrey score &gt; 32 compatible histological result ) centrally randomize C-NAC C group . Both group receive 4 week prednisolone treatment , plus NAC combination therapy group ( D1 : 150 , 50 100 mg/kg 250 , 500 1000 mL 5 % glucose-saline ( G5 % ) respectively , t=30 minute , 4 16 hour ; D2 D5 , 100 mg/kg 1000 mL G5 % ) . Group C receive 1000 mL G5 % , D1-5</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Patient consent Chronic alcohol intake last 3 6 month Maddrey score ≥ 32 Liver histology compatible Hepato renal syndrome Hepatocarcinoma Recent variceal haemorrhage Recent bacterial infection Other liver disease associate ( HCV , HBV , hemochromatosis , AIH ) Cancers cardiac respiratory , HIV infection NAC Allergy No patient consent Acetaminophen intoxication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Acute Alcoholic Hepatitis</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Alcoholic Liver disease</keyword>
</DOC>